BMJ Publishing Group Limited
|Agreement labeling||BMJ Publish and Read 2021 Pilot Agreement|
|Has the agreement been disclosed and published?||Yes|
|Agreement period||01/01/2021 – 12/31/2021|
|Consortia / Institution||Jisc|
Approximate range of annual corresponding author publications
|Comments on size/article output||Publishing fund pot is based on the current subscribing consortia’s 2018/19 average funded output|
How do the costs of the agreement relate to previous subscription-only agreements with the publisher?
|Comments on cost development||75% of total consortium fee invested into the publishing fund|
Transfomative agreements vary by their transformative mechanisms, meaning the way in which financing is shifted from the subscription side to open access publishing. What are the characteristics of this agreement to this regard?
|Subscriptions partly converted to OA publishing fees|
Are all journals relevant to your affiliated authors (in which you expect them to publish) eligible for OA publishing under the agreement?
|Are fully open access journals covered by the agreement?||No|
|OA LICENSE||CC-BY mandatory|
||Original research articles|
What is the approximate share of access related costs of the overall agreement?
|Comments on access costs||Perm read fee (25%)|
Are all read relevant journals covered by the agreement?
|PERPETUAL ACCESS RIGHTS||Yes|
|WORKFLOW ASSESSMENT||Too early to assess|
|OVERALL ASSESSMENT AND COMMENTS||Transitions all funded UKHEI output (current participating consortium) to OA, based on 2018/19 average output, to within the publishing fund cap. Agreement meets funder mandates for 2021. This is a pilot agreement for 2021, will a view to review terms for 2022.|
|Request contact to the licensee||contact [at] esac-initiative [dot] org|